|
1
|
Dechering K, Boersma C and Mosselman S:
Estrogen receptors alpha and beta: two receptors of a kind? Curr
Med Chem. 7:561–576. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Syed F and Khosla S: Mechanisms of sex
steroid effects on bone. Biochem Biophys Res Commun. 328:688–696.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Li LZ, Zhang YL, Zhu YQ, Wu J and
Sun WJ: LC, a novel estrone-rhein hybrid compound, concurrently
stimulates osteoprotegerin and inhibits receptor activator of
NF-kappaB ligand (RANKL) and interleukin-6 production by human
osteoblastic cells. Mol Cell Endocrinol. 337:43–51. 2011.
View Article : Google Scholar
|
|
4
|
López-Marcos JF, García-Valle S and
García-Iglesias AA: Periodontal aspects in menopausal women
undergoing hormone replacement therapy. Med Oral Patol Oral Cir
Bucal. 10:132–141. 2005.(In English and Spanish).
|
|
5
|
Tarakji B, Nassani MZ and Sloan P:
Immunohistochemical expression of estrogens and progesterone
receptors in carcinoma ex pleomorphic adenoma-undifferentiated and
adenocarcinoma types. Med Oral Patol Oral Cir Bucal. 15:e432–e436.
2010. View Article : Google Scholar
|
|
6
|
Coelingh Bennink HJ: Are all estrogens the
same? Maturitas. 47:269–275. 2004.PubMed/NCBI
|
|
7
|
Qu Q, Perälä-Heape M, Kapanen A, et al:
Estrogen enhances differentiation of osteoblasts in mouse bone
marrow culture. Bone. 22:201–209. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Li LZ, Zhang YL, et al: LC, a
novel estrone-rhein hybrid compound, promotes proliferation and
differentiation and protects against cell death in human
osteoblastic MG-63 cells. Mol Cell Endocrinol. 344:59–68. 2011.
View Article : Google Scholar
|
|
9
|
Park JB: Effects of fibroblast growth
factor 2 on osteoblastic proliferation and differentiation by
regulating bone morphogenetic protein receptor expression. J
Craniofac Surg. 22:1880–1882. 2011. View Article : Google Scholar
|
|
10
|
Odabaş ME, Ertürk M, Çinar Ç, Tuzüner T
and Tulunoğlu Ö: Cytotoxicity of a new hemostatic agent on human
pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal.
16:e584–e587. 2011.PubMed/NCBI
|
|
11
|
Luo XH and Liao EY: Effects of estriol on
the proliferation and differentiation of human osteoblastic MG-63
cells. Endocr Res. 29:343–351. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JB: The effects of dexamethasone,
ascorbic acid, and beta-glycerophosphate on osteoblastic
differentiation by regulating estrogen receptor and osteopontin
expression. J Surg Res. 173:99–104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Todorovic T, Dozic I, Vicente-Barrero M,
et al: Salivary enzymes and periodontal disease. Med Oral Patol
Oral Cir Bucal. 11:E115–E119. 2006.(In Spanish and English).
|
|
14
|
Fernández-Tresguerres-Hernández-Gil I,
Alobera-Gracia MA, del-Canto-Pingarrón M and Blanco-Jerez L:
Physiological bases of bone regeneration. I. Histology and
physiology of bone tissue. Med Oral Patol Oral Cir Bucal.
11:E47–E51. 2006.(In English and Spanish).
|
|
15
|
Park JB: Effects of doxycycline,
minocycline, and tetracycline on cell proliferation,
differentiation, and protein expression in osteoprecursor cells. J
Craniofac Surg. 22:1839–1842. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pinzone JJ, Stevenson H, Strobl JS and
Berg PE: Molecular and cellular determinants of estrogen receptor
alpha expression. Mol Cell Biol. 24:4605–4612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang W, Carlsen B, Rudkin G, et al:
Osteopontin is a negative regulator of proliferation and
differentiation in MC3T3-E1 preosteoblastic cells. Bone.
34:799–808. 2004. View Article : Google Scholar : PubMed/NCBI
|
